-
Je něco špatně v tomto záznamu ?
Clinical isolates of Escherichia coli are resistant both to antibiotics and organotin compounds
M. Aguilar-Santelises, J. Castillo-Vera, R. Gonzalez-Molina, A. Garcia Del Valle, M. Cruz Millan, L. Aguilar-Santelises,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
2016-279-1-156
Instituto Politécnico Nacional (MX)
- MeSH
- antibakteriální látky farmakologie MeSH
- Escherichia coli účinky léků MeSH
- infekce močového ústrojí mikrobiologie MeSH
- infekce vyvolané Escherichia coli mikrobiologie MeSH
- karbonylkyanid-m-chlorfenylhydrazon farmakologie MeSH
- lidé MeSH
- membránové transportní proteiny metabolismus MeSH
- mikrobiální testy citlivosti MeSH
- mnohočetná bakteriální léková rezistence * MeSH
- organocínové sloučeniny farmakologie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Antibiotic-resistant Escherichia coli are common causative agents of human urinary tract infections. Organotin compounds (OTCs) are man-made chemicals that may affect the renal function of exposed humans and rodents. OTCs are widely recognized as bactericides. However, many environmental and a few clinically relevant bacteria have been found resistant to high concentrations of some OTCs. We examined the susceptibility from 47 E. coli clinical isolates to 12 antibiotics and 5 OTCs. Minimum inhibitory concentrations were determined by the fully automated Sensititre™ ARIS™ 2X system, and E. coli strains were classified as resistant, intermediate resistant, or sensitive, according to the M07-A10 and M100-S26 criteria from the National Committee for Clinical Laboratory Standards. All 47 E. coli strains were susceptible to amikacin but resistant to imipenem and intermediate resistant to ampicillin, cefuroxime, and chloramphenicol. In addition, 26 strains were resistant and 21 intermediate resistant to aztreonam, 24 strains were resistant and 23 intermediate resistant to ceftazidime, 44 strains were intermediate resistant and 3 sensitive to cephalothin, and 43 strains were intermediate resistant and 4 sensitive to ciprofloxacin. Approximately half of the strains were susceptible to cefepime, cefotaxime, and gentamicin. E. coli strains were also found resistant to triphenyltin, tributyltin, dibutyltin, trimethyltin, or dimethyltin at final concentration between 10 μmol/L and 1 mmol/L, during 72-h in vitro culture. However, higher in vitro growth inhibition was induced by these OTCs in the presence of the efflux pump inhibitor carbonyl cyanide-m-chlorophenyl hydrazone, which suggests that efflux pumps contribute to making antibiotic-resistant E. coli also resistant to OTCs.
Faculty for Higher Education Zaragoza UNAM Mexico City Mexico
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20024249
- 003
- CZ-PrNML
- 005
- 20201208102223.0
- 007
- ta
- 008
- 201208s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-019-00707-1 $2 doi
- 035 __
- $a (PubMed)31001763
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Aguilar-Santelises, M $u National School of Biological Sciences, IPN, Mexico City, Mexico. maguilarsa@ipn.mx. Departamento de Microbiologia, Escuela Nacional de Ciencias Biologicas, IPN, Prolongacion de Carpio y Plan de Ayala, Col. Santo Tomas, Del. Miguel Hidalgo, 11340, Mexico City, Mexico. maguilarsa@ipn.mx.
- 245 10
- $a Clinical isolates of Escherichia coli are resistant both to antibiotics and organotin compounds / $c M. Aguilar-Santelises, J. Castillo-Vera, R. Gonzalez-Molina, A. Garcia Del Valle, M. Cruz Millan, L. Aguilar-Santelises,
- 520 9_
- $a Antibiotic-resistant Escherichia coli are common causative agents of human urinary tract infections. Organotin compounds (OTCs) are man-made chemicals that may affect the renal function of exposed humans and rodents. OTCs are widely recognized as bactericides. However, many environmental and a few clinically relevant bacteria have been found resistant to high concentrations of some OTCs. We examined the susceptibility from 47 E. coli clinical isolates to 12 antibiotics and 5 OTCs. Minimum inhibitory concentrations were determined by the fully automated Sensititre™ ARIS™ 2X system, and E. coli strains were classified as resistant, intermediate resistant, or sensitive, according to the M07-A10 and M100-S26 criteria from the National Committee for Clinical Laboratory Standards. All 47 E. coli strains were susceptible to amikacin but resistant to imipenem and intermediate resistant to ampicillin, cefuroxime, and chloramphenicol. In addition, 26 strains were resistant and 21 intermediate resistant to aztreonam, 24 strains were resistant and 23 intermediate resistant to ceftazidime, 44 strains were intermediate resistant and 3 sensitive to cephalothin, and 43 strains were intermediate resistant and 4 sensitive to ciprofloxacin. Approximately half of the strains were susceptible to cefepime, cefotaxime, and gentamicin. E. coli strains were also found resistant to triphenyltin, tributyltin, dibutyltin, trimethyltin, or dimethyltin at final concentration between 10 μmol/L and 1 mmol/L, during 72-h in vitro culture. However, higher in vitro growth inhibition was induced by these OTCs in the presence of the efflux pump inhibitor carbonyl cyanide-m-chlorophenyl hydrazone, which suggests that efflux pumps contribute to making antibiotic-resistant E. coli also resistant to OTCs.
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a karbonylkyanid-m-chlorfenylhydrazon $x farmakologie $7 D002258
- 650 12
- $a mnohočetná bakteriální léková rezistence $7 D024901
- 650 _2
- $a Escherichia coli $x účinky léků $7 D004926
- 650 _2
- $a infekce vyvolané Escherichia coli $x mikrobiologie $7 D004927
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a membránové transportní proteiny $x metabolismus $7 D026901
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a organocínové sloučeniny $x farmakologie $7 D009947
- 650 _2
- $a infekce močového ústrojí $x mikrobiologie $7 D014552
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Castillo-Vera, J $u National School of Biological Sciences, IPN, Mexico City, Mexico. General Hospital of Zone 57, Cuautitlán Izcalli, Mexico.
- 700 1_
- $a Gonzalez-Molina, R $u General Hospital of Zone 57, Cuautitlán Izcalli, Mexico.
- 700 1_
- $a Garcia Del Valle, A $u Faculty for Higher Education Zaragoza, UNAM, Mexico City, Mexico.
- 700 1_
- $a Cruz Millan, M $u Faculty for Higher Education Zaragoza, UNAM, Mexico City, Mexico.
- 700 1_
- $a Aguilar-Santelises, L $u Faculty for Higher Education Zaragoza, UNAM, Mexico City, Mexico.
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 65, č. 1 (2020), s. 87-94
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31001763 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20201208 $b ABA008
- 991 __
- $a 20201208102219 $b ABA008
- 999 __
- $a ok $b bmc $g 1593204 $s 1114930
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 65 $c 1 $d 87-94 $e 20190417 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
- GRA __
- $a 2016-279-1-156 $p Instituto Politécnico Nacional (MX)
- LZP __
- $a Pubmed-20201208